Is Long-acting Cabotegravir a Pre-exposure Prophylaxis Option for Women of Childbearing Potential? Article (Faculty180)

cited authors

  • Sahloff, Eric G; Hamons, Nikki; Baumgartner, Kevin; Duggan, Joan M

description

  • Long-acting cabotegravir (CAB-LA) provides an exciting new option for pre-exposure prophylaxis (PrEP) in multiple populations. In this Perspective, we consider the unique pharmacokinetics of CAB-LA and the potential impact on the prescribing of CAB-LA, specifically in cis-women of reproductive potential.

authors

publication date

  • 2022

published in

start page

  • ofac230

volume

  • 9